GlucoTrack, Inc. (GCTK)
2.93
-0.05
(-1.68%)
USD |
NASDAQ |
Sep 08, 16:00
2.97
+0.04
(+1.37%)
Pre-Market: 09:15
GlucoTrack Total Liabilities (Quarterly) : 3.236M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.236M |
| March 31, 2026 | 5.207M |
| December 31, 2025 | 5.01M |
| September 30, 2025 | 5.539M |
| June 30, 2025 | 3.33M |
| March 31, 2025 | 2.354M |
| December 31, 2024 | 18.93M |
| September 30, 2024 | 4.848M |
| June 30, 2024 | 3.897M |
| March 31, 2024 | 1.73M |
| December 31, 2023 | 1.708M |
| September 30, 2023 | 1.638M |
| June 30, 2023 | 1.239M |
| March 31, 2023 | 1.24M |
| December 31, 2022 | 1.208M |
| September 30, 2022 | 1.156M |
| June 30, 2022 | 1.127M |
| March 31, 2022 | 1.128M |
| December 31, 2021 | 1.11M |
| September 30, 2021 | 1.132M |
| June 30, 2021 | 1.321M |
| March 31, 2021 | 1.479M |
| December 31, 2020 | 1.624M |
| September 30, 2020 | 1.526M |
| June 30, 2020 | 1.791M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.386M |
| December 31, 2019 | 2.508M |
| September 30, 2019 | 2.836M |
| June 30, 2019 | 3.040M |
| March 31, 2019 | 3.525M |
| December 31, 2018 | 3.562M |
| September 30, 2018 | 5.032M |
| June 30, 2018 | 5.066M |
| March 31, 2018 | 4.770M |
| December 31, 2017 | 4.822M |
| September 30, 2017 | 4.071M |
| June 30, 2017 | 3.873M |
| March 31, 2017 | 4.389M |
| December 31, 2016 | 3.369M |
| September 30, 2016 | 2.198M |
| June 30, 2016 | 2.211M |
| March 31, 2016 | 2.824M |
| December 31, 2015 | 2.167M |
| September 30, 2015 | 1.556M |
| June 30, 2015 | 1.570M |
| March 31, 2015 | 2.068M |
| December 31, 2014 | 3.432M |
| September 30, 2014 | 3.282M |
| June 30, 2014 | 3.377M |
| March 31, 2014 | 9.497M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Nuwellis, Inc. | 11.17M |
| Abbott Laboratories | 57.45B |
| DexCom, Inc. | 3.834B |
| Insulet Corp. | 1.743B |
| AngioDynamics, Inc. | 96.34M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.495M |
| Shareholders Equity (Quarterly) | -1.741M |
| Debt to Equity Ratio | -1.125 |
| Current Ratio | 0.4622 |
| Net Debt Paydown Yield | -17.00% |